Akbarian, S. et al., Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics, en Arch Gen Psychiatry, 52, 1995.
Albert, K. A. et al., Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia, en Arch Gen Psychiatry, 59, 2002.
Bogerts, B. et al., Reduced temporal limbic structures volumes on magnetic resonance images in first episode schizophrenia, en Psychiatry Res., 35, 1990.
Brazelton, T.B. y Cramer, B.G., The earliest relationship, Addison-Wes- ley, MA, 1990.
Carlsson A., Antipsychotic drugs and catecholamine synapses, en J Psychiatr Res, 11, 1974.
Cocks, J.A. et al., Effects of thyroid hormone on the biochemical maturation of rat brain: conversión of glucosa-carbon into amino acids, en Journal of neurochemistry, 17, 1970.
Coyle, J., The nagging question of the function of N-acetylaspartateglu- tamate, en Neurobiol. Dis., 4, 1997.
Craig, A.D. et al., Thermosensory activation of insular cortex, en Nature Neuroscience, 3, 2000.
Craig, A.D., How do you feel? Interoception: the sense of the physiological condition of the body, en Nature Reviews Neuroscience, 3, 2002.
Crook, J.M. et al., Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann’s areas 8,9,10, and 46 and the effects of neuroleptic drug treatment, en Am J Psychiatry, 158, 6, 2001.
Dracheva, S. et al., N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia, en Am J Psychiatry 158, 9, 2001.
Gaser, C. et al., Ventricular enlargement in schizophrenia related to volume reduction of the thalamus, striatum, and superior temporal cortex, en Am J Psychiatry, 161, 1, 2004.
Gattaz, W.F. et al., Glutamate in schizophrenics and healthy Controls, en Arch Psychiatr Nervenkr., 231, 1982.
Goff, D.C. et al., Folate, homocysteine, and negative symptons in schizophrenia, en Am J Pychiatry 161, 9, 2004.
Huttenlocher, P.R., Synapse elimination and plasticity in developing human cerebral cortex, en American Journal of Mental Deficiency, 88, 1984.
Javitts, D.O. et al., Recent advances in the phencyclidine model of schizophrenia, en Am J Psychiatry, 148, 1991.
Kandel, E. R., Schwartz J.H. y Jessell, T.M., Principies of neural Science, McGraw-Hill, New York, 2000.
Kasai, K. et al., Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affective psicosis, en Arch Gen Psychiatry, 60, 2003.
Kim, J. S. et al., Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia, en Neurosci Lett, 20, 1980.
Knapp, A. G. et al., Dopamine modulates the kinetics of ion channels gated by excitatory aminoacids in retinal horizontal cells, en Proceedings of the National Academy of Sciences of the United States of America, 87, 1990.
Kotter, R., Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum, en Prog. Neurobiol., 44, 1994.
Lahti, A.C. y Holcomb, H.H., Pharmacologic models, en Am J Psychiatry, 160, 12, 2003.
Lewis, D.A., Neural circuitry of the prefrontal cortex in schizophrenia, en Arch Gen Psychiatry, 52, 1995.
Marchbanks, R. M. et al., Aspects of oxidative metabolism in schizophrenia, en British Journal of Psychiatry, 167, 1995.
McCabe, B. J. y Hom, G., Leaming and Memory: regional changes in N-me- thyl-D-aspartate receptors in the chick brain after imprinting, en Proceedings of the National Academy of Sciences of the United States of America, 85, 1988.
McGowan, S. et al., Presynaptic dopaminergic dysfunction in schizophrenia. A position emission tomographic
[ 18 F] fluorodopa study, en Arch Gen Psychiatry, Vol. 61, 2004.
Mora, F. y Cobo, M., The neurobiological basis of prefrontal cortex selfstimulation: a review and an integrative hypothesis, en Progress in Brain Research, 85, 1990.
Niendam, T.A. et al., A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings, en Am J Psychiatry, 160, 11,2003.
Panksepp, J., Affective Neuroscience: The foundations of human and animal emotions, Oxford University Press, New York, 1998.
Pycock C. J. et al., Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats, en Nature, 286, 1980.
Resnick, O. et al., LSD-25 action in normal subjects treated with a monoamine oxidase inhibitor, en Life Sci., 3, 1964.
Rogeness, G.A. y McClure, E.B., Development and neurotransmitter-en- vironmental interactions, en Development and Psychopathology, 8, 1996.
Rotenberg, V.S., An Integrad ve psychophysiological approach to brain hemisphere functions in schizophrenia, en Neuroci. Behav. Rev., 18, 1994.
Schore A. N., Affect dysregulation and disorders of the self, W.W. Norton and Company, New York, 2003.
Siever, L. J. y Davis, K.L., The pathophysiology of schizophrenia disorders: perspectives from the spectrum, en Am J Psychiatry, 161, 3, 2004.
Smith, R.E., Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia, en Am J Psychiatry, 158, 9, 2001.
Solms, M. y Tumbull, O., The brain and the inner world. An introduction to the neuroscience of subjective experience, Other Press, New York, 2002.
Spear, L.P., The Adolescent brain and age-related behavioral manifestations, en Neuroscience and Biobehavioral Reviews, 24, 2000.
Stahl, S., Essential psychopharmacology. Neuroscientific basis and practical applications, Cambridge University Press, New York, 2000.
Sullivan, P.F. et al, Schizophrenia as a complex trait. Evidence from a meta-analysis of twin studies, en Arch Gen Psychiatry, 60, 2003.
Tassin, J.P., Peut-on trouver un lien entre Tinconscient psychanalytique et les connaissances actuelles en neurologie? en Neuropsy., 4,8, 1989.
Théberge, J. et al., Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T Proton MRS, en Am J Psychiatry, 160, 12, 2003.
Tibbo, P. et al., 3-T proton MRS investigation of glutamate and glutami- ne in adolescents at high genetic risk for schizophrenia, en Am J Psychiatry, 161, 6, 2004.
Tsai, G. et al., Abnormal excitatory neurotransmitter metabolism in schizophrenic brains, en Arch Gen Psychiatry, 52, 1995.
Weinberger, D.R. et al., Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: regional cerebral blood flow (rCBF) evidence, en Arch Gen Psychiatry, 43, 1986.
Weinberger, D.R., Implications of normal brain development for the pathogenesis of schizophrenia, en Arch Gen Psychiatry, 44, 1987.
Yasuno, F. et al., Low dopamine D2 receptor binding in subregions of the thalamus in schizophrenia, en Am J Psychiatry, 161, 6, 2004.
